News | December 01, 2023
Biocon Biologics completes Integration of Viatris' Biosimilar business
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Both the India and GCC entities will be operated by separate dedicated management teams
This collaboration underscores WOTR's unwavering commitment to strengthening rural communities against the unpredictable variations of climate change
Total transaction value of the divestment is Rs. 3,660 million
The company expects that this development could improve the strength of its application to the FDA for new drug approval
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
